Brumm Joshua T (CIK 0001528826)

Latest company ownership

Shares held
50,000
Last filed at
Mar 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 8, 2024 Mar 12, 2024 Dyne Therapeutics, Inc. CEO Sell 21.3 -429,730 -9.64% $11.1M
Mar 7, 2024 Mar 11, 2024 Dyne Therapeutics, Inc. CEO Sell 45.0 -9,086 -1.61% $234.9K
Feb 29, 2024 Mar 1, 2024 Dyne Therapeutics, Inc. CEO Sell 32.5 -100,000 -4.11% $2.9M
Jan 3, 2024 Jan 4, 2024 Dyne Therapeutics, Inc. CEO Sell 22.5 -269,719 -8.21% $5M
Dec 11, 2023 Dec 12, 2023 Dyne Therapeutics, Inc. Officer Sell 45.0 -7,585 -1.28% $81.3K
Sep 18, 2023 Sep 20, 2023 Dyne Therapeutics, Inc. Officer Sell 37.5 -12,032 -4.90% $113.2K
Sep 12, 2023 Sep 13, 2023 Dyne Therapeutics, Inc. Officer Sell 37.5 -7,672 -3.03% $79.9K
Jun 8, 2023 Jun 12, 2023 Dyne Therapeutics, Inc. Officer Sell 17.5 -347,130 -17.12% $4.2M
Mar 14, 2023 Mar 15, 2023 Dyne Therapeutics, Inc. Officer Sell 41.3 -7,318 -2.22% $97.5K
Dec 9, 2022 Dec 13, 2022 Dyne Therapeutics, Inc. Officer Sell 91.3 +140,678 74.38% $36.1K
Oct 7, 2022 Oct 11, 2022 Dyne Therapeutics, Inc. Officer Sell 17.5 -225,500 -22.21% $2.6M
Sep 20, 2022 Sep 21, 2022 Dyne Therapeutics, Inc. Officer Sell 32.5 -11,836 -5.47% $162.2K
Sep 15, 2022 Sep 15, 2022 Dyne Therapeutics, Inc. Officer Sell 48.8 -3,480 -1.58% $48.9K
Jul 5, 2022 Jul 6, 2022 Dyne Therapeutics, Inc. Officer Sell 90.0 +13,155 6.36% $90.3K
Jun 14, 2022 Jun 15, 2022 Dyne Therapeutics, Inc. Officer Sell 48.8 -3,540 -1.68% $17.5K
Mar 11, 2022 Mar 14, 2022 Dyne Therapeutics, Inc. Officer Sell 48.8 -3,384 -1.58% $29.5K
Sep 20, 2021 Sep 22, 2021 Dyne Therapeutics, Inc. Officer Sell 32.5 -8,009 -7.48% $127.3K